We are validating QCxMS2 against the test set in Gorges, Engeser, Grimme (2025),
Evaluation of the QCxMS2 method for the calculation of collision-induced
dissociation spectra. Most cases reproduce well, but leucine ([M+H]+, CID)
comes out inverted relative to the paper: the -NH3 loss (m/z 116) is our base
peak and the diagnostic immonium ion (m/z 86) is essentially absent — the paper
reports ESS 0.934 with the immonium as a dominant peak.
We have ruled out every setting we can access and now suspect a CREST /
MSREACT version difference (paper: CREST 1.1.3; ours: CREST 3.0.2). We would
be grateful for your guidance.
Environment
| Component |
Ours |
Paper |
| QCxMS2 |
1.2.0 (4db5131), compiled 2025-07-10 |
(please confirm) |
| CREST |
3.0.2 (2025-08-05) |
1.1.3 |
| xtb |
6.7.1 (edcfbbe), 2026-06-10 |
(please confirm) |
| ORCA |
6.1.0 |
6.0.0 |
| OS |
WSL2 (Ubuntu) on Windows; qcxms2 run in native Linux dir |
— |
Command (composite level = paper's leucine method)
qcxms2 input.xyz -cid -chrg 1 -esiatom 0.250 -pthr 5 \
-geolevel gfn2 -tslevel wb97x3c \
-iplevel gfn2 -ip2level wb97x3c -mthr 10 -T 20
Observed vs expected (leucine [M+H]+, m/z 132.10)
| m/z |
assignment |
our intensity (base=100) |
paper |
| 116.07 |
-NH3 |
100 (base) |
minor |
| 132.10 |
[M+H]+ precursor |
~68 |
precursor |
| 86.10 |
immonium (diagnostic) |
~2 (near 0) |
dominant |
So -NH3 loss (116) dominates and the immonium (86) is essentially absent — the
inverse of the published spectrum.
What we have already ruled out
- Protomer choice: forced protomer index 1 (O-protonated); also tried the
automatic Boltzmann ranking (r2SCAN-3c Opt Freq + mRRHO 548 K + SMD water).
- -pthr: used 5 (your paper value). At the qcxms2 default of 1% the immonium
is further fragmented (to ~m/z 43), so 5% is clearly correct.
- esiatom: 0.25 (also tried higher).
- -msnoiso: enabling it made things WORSE — it removed the immonium (m/z 86
-> 0) while leaving -NH3 (116) as base peak. (The immonium channel is itself
rearrangement-mediated, so -msnoiso suppresses the peak we want.)
- Full-DFT geometries (extra check, beyond the paper's leucine level):
-geolevel wb97x3c -tslevel wb97x3c did NOT complete within a 72-hour wall
limit for this 22-atom molecule (still in the NEB transition-state phase at
72 h). So we cannot resolve this by raising the geometry level of theory; it
points upstream to MSREACT fragment generation.
We could NOT test the paper's CREST version — and here is why
- CREST 1.1.3 (the paper's version) is not on conda-forge, which packages
only 2.11.1, 2.11.2, 2.12, and 3.0.2.
- We installed the closest available (CREST 2.12 + matched xtb 6.4.0) in
an isolated env and invoked QCxMS2 1.2.0 with it on the same input. QCxMS2
aborted at startup, before any fragmentation:
forrtl: severe (124): Invalid command supplied to EXECUTE_COMMAND_LINE
Image PC Routine Line Source
qcxms2 ... utility_mp_check_ 1260 utility.f90
qcxms2 ... argparser_mp_chec 630 argparser.f90
qcxms2 ... MAIN__ 91 main.f90
- On investigation, CREST 2.12 has no MSREACT capability at all — it does not
recognize --msreact / --msfulliso / --msnoiso, and its --help lists no
reaction/fragmentation options. MSREACT post-dates the conda-forge 2.x line.
- Therefore the only conda-forge CREST that can drive QCxMS2 1.2.0 is 3.x, and
we cannot reproduce the paper's CREST 1.1.3 + MSREACT toolchain locally.
Questions
- Which exact CREST and QCxMS2 versions produced the leucine result in the
paper (ESS 0.934)? Is our discrepancy consistent with an MSREACT change
between CREST 1.1.3 and 3.0.2?
- Could you point us to the CREST 1.1.3 build used for the paper (it is not
on conda-forge), and confirm which QCxMS2 version it pairs with? We would like
to reproduce the published toolchain.
- Are there MSREACT settings (reaction-type restrictions, number of
fragmentation attempts, isomerization handling) used for the paper that are
not current defaults?
- Is -NH3 dominance over the immonium a known artifact for amino acids at
this version, and is there a mitigation that does NOT also suppress the
immonium (i.e. not -msnoiso)?
- Given full-DFT geometries are impractical here, do you consider the issue to
be upstream in fragment generation (MSREACT) rather than in the barriers?
Files we can provide
input.xyz (protonated protomer-1 geometry)
qcxms2.log (composite run)
allpeaks.dat / peaks.csv
qcxms2_crest212.log (the severe-124 startup abort with CREST 2.12)
Happy to attach any of these or run additional diagnostics. Thank you very much
for QCxMS2 and for any guidance.
Verbatim external-program commands used (from our run logs)
# Protomer generation:
crest seed.xyz -protonate -ewin 60 -gfn2 -T 20
# Protomer dedup:
molbar protomer_<k>.xyz -c 1 -m mb
# Protomer Gibbs ranking (ORCA):
! r2SCAN-3c Opt Freq
%cpcm smd true smdsolvent "water" end
%freq Temp 548 end
# Conformer search (verbatim):
crest best_protomer.xyz -gfn2 -T 20 -chrg 1
# Fragment NEB-TS (ORCA, verbatim from a fragment dir):
! NEB
! UKS wB97X-3c
! LOOSESCF
%maxcore 8000
%pal nprocs 1 end
%NEB NEB_END_XYZFILE "end.xyz"
NImages 7
MaxIter 500
end
*xyzfile 1 1 start.xyz
# Main fragmentation (composite):
qcxms2 input.xyz -cid -chrg 1 -esiatom 0.250 -pthr 5 \
-geolevel gfn2 -tslevel wb97x3c -iplevel gfn2 -ip2level wb97x3c \
-mthr 10 -T 20
Any insight is much appreciated.
Thanks,
Michael Mawn
We are validating QCxMS2 against the test set in Gorges, Engeser, Grimme (2025),
Evaluation of the QCxMS2 method for the calculation of collision-induced
dissociation spectra. Most cases reproduce well, but leucine ([M+H]+, CID)
comes out inverted relative to the paper: the -NH3 loss (m/z 116) is our base
peak and the diagnostic immonium ion (m/z 86) is essentially absent — the paper
reports ESS 0.934 with the immonium as a dominant peak.
We have ruled out every setting we can access and now suspect a CREST /
MSREACT version difference (paper: CREST 1.1.3; ours: CREST 3.0.2). We would
be grateful for your guidance.
Environment
Command (composite level = paper's leucine method)
Observed vs expected (leucine [M+H]+, m/z 132.10)
So -NH3 loss (116) dominates and the immonium (86) is essentially absent — the
inverse of the published spectrum.
What we have already ruled out
automatic Boltzmann ranking (r2SCAN-3c Opt Freq + mRRHO 548 K + SMD water).
is further fragmented (to ~m/z 43), so 5% is clearly correct.
-> 0) while leaving -NH3 (116) as base peak. (The immonium channel is itself
rearrangement-mediated, so -msnoiso suppresses the peak we want.)
-geolevel wb97x3c -tslevel wb97x3cdid NOT complete within a 72-hour walllimit for this 22-atom molecule (still in the NEB transition-state phase at
72 h). So we cannot resolve this by raising the geometry level of theory; it
points upstream to MSREACT fragment generation.
We could NOT test the paper's CREST version — and here is why
only 2.11.1, 2.11.2, 2.12, and 3.0.2.
an isolated env and invoked QCxMS2 1.2.0 with it on the same input. QCxMS2
aborted at startup, before any fragmentation:
recognize
--msreact/--msfulliso/--msnoiso, and its--helplists noreaction/fragmentation options. MSREACT post-dates the conda-forge 2.x line.
we cannot reproduce the paper's CREST 1.1.3 + MSREACT toolchain locally.
Questions
paper (ESS 0.934)? Is our discrepancy consistent with an MSREACT change
between CREST 1.1.3 and 3.0.2?
on conda-forge), and confirm which QCxMS2 version it pairs with? We would like
to reproduce the published toolchain.
fragmentation attempts, isomerization handling) used for the paper that are
not current defaults?
this version, and is there a mitigation that does NOT also suppress the
immonium (i.e. not -msnoiso)?
be upstream in fragment generation (MSREACT) rather than in the barriers?
Files we can provide
input.xyz(protonated protomer-1 geometry)qcxms2.log(composite run)allpeaks.dat/peaks.csvqcxms2_crest212.log(the severe-124 startup abort with CREST 2.12)Happy to attach any of these or run additional diagnostics. Thank you very much
for QCxMS2 and for any guidance.
Verbatim external-program commands used (from our run logs)
Any insight is much appreciated.
Thanks,
Michael Mawn